+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

HIP Resident Award

American Society of Hematology

The HIP Resident Award Program supports first- and second-year medical residents from a workforce that reflects the patient population it serves in hematology across the U.S., Canada, and Mexico. As part of the Hematology Inclusion Pathway, the HIP Resident Award provides participants with funds to conduct blood science research under the mentorship of an ASH member. Residents also receive career development mentorship from ASH members, gain valuable hematology knowledge, and benefit from complimentary ASH membership. Recipients also receive a honorarium to attend the ASH annual meeting to present their research.

Eligible candidates include those in internal medicine, pathology, pediatric residencies, and residents who have applied to or matched early into a hematology-oncology fellowship program.

Program Benefits

Participants receive a $5,000 honorarium to support their research project, $1,000 for attending the ASH annual meeting, $1,000 after the meeting for presenting their research at the annual meeting, and complimentary ASH membership throughout residency.

AI Based Application Success Predictor

1. Clear Alignment with Hematology

This is the strongest predictor.

Successful proposals:

Focus squarely on blood disorders or blood biology

Address malignant or non-malignant hematology, transfusion medicine, hemostasis/thrombosis, stem cell biology, or related areas

Clearly state why the work is hematology-specific, not generic biomedical research

❌ Projects that could belong equally to oncology, immunology, or genetics without a hematologic core are less competitive.

2. Scientific Excellence & Rigor

ASH uses NIH-style peer review standards.

Winning applications show:

A strong hypothesis or central question

Sound experimental or clinical design

Appropriate methods and analysis plans

Feasible scope for the funding level and timeline

ASH reviewers are particularly sensitive to over-ambitious aims.

3. Career-Stage Fit (Critical)

ASH awards are highly career-stage specific.

Program	Best-Fit Applicant
ASH Fellow Scholar Award	Fellows / postdocs
ASH Junior Scholar Award	Early faculty (≈ ≤5 years)
ASH Bridge Grant	Investigators between major funding
CRTI	Early clinical investigators
Trainee/Abstract Awards	Students, residents, fellows

📌 Mismatch between applicant stage and award intent is a common reason for rejection.

4. Strong Mentorship & Environment

For Fellow and Junior Scholar Awards, mentorship quality is decisive.

Successful applications include:

Named mentors with hematology expertise

Clear mentor roles (scientific, career, clinical)

Evidence the environment supports independence

Institutional commitment (protected time, resources)

ASH heavily values mentorship track record.

5. Clear Path to Independence or Future Funding

ASH funding is often seen as a launchpad.

Competitive proposals explain:

How results will lead to NIH / CIHR / ERC / MRC-style grants

How the award supports transition to independence

Planned publications, datasets, or clinical protocols

ASH Bridge Grants explicitly require a credible plan for renewed external funding.

6. Impact on Hematology Practice or Knowledge

ASH values both:

Mechanistic insight (biology of blood disorders)

Clinical relevance (diagnosis, prognosis, therapy, outcomes)

Successful applications clearly state:

“How will this change understanding, management, or future research in hematology?”

7. Equity, Diversity & Workforce Development (Increasingly Important)

ASH explicitly prioritizes:

Diversity in the hematology workforce

Support for underrepresented groups

Global hematology capacity building

Applications that naturally integrate:

Diverse populations

Health disparities

Inclusive training environments
often score more favorably when scientifically strong.

8. Clear, Polished Writing

ASH panels are multidisciplinary.

Strong applications:

Use clear, jargon-controlled language

Define disease relevance early

Avoid overly technical explanations without context

Present a logical, compelling narrative

Even excellent science can fail with poor clarity.

🚫 Common Reasons ASH Applications Fail

Weak or indirect connection to hematology

Career-stage mismatch

Over-ambitious aims for the award size

Thin mentorship plan

No clear future funding trajectory

Unclear clinical or biological impact

📊 Summary: ASH Success Predictors

Predictor	Importance
Hematology-centered focus	Essential
Scientific rigor & feasibility	Essential
Career-stage alignment	Essential
Strong mentorship	Very high
Path to independence/funding	Very high
Impact on hematology	High
Diversity & workforce considerations	Moderate–High
Clear writing & structure	High

✅ Practical Tips Before You Apply

Choose the exact ASH mechanism that matches your career stage

State hematologic relevance in the first paragraph

Keep aims tight and achievable

Invest in mentor letters—they matter

Explicitly describe next funding steps

Specialties

Hematology

Eligibility Requirements

At the time of application, the applicant must:

Provide a response to the HIP question articulating how the applicant advances the goals of the initiative.
Any visa, citizenship, and/or U.S. work authorization restrictions applicable to receiving the ASH Award are the responsibility of the applicant.
Be planning and committed to conducting the relevant research project in the United States, Canada, or Mexico with an ASH member mentor.
Be enrolled in an internal medicine, pathology, or pediatric residency program in the United States or Canada that is approved by the Accreditation Council for Graduate Medical Education (ACGME) or Royal College Physicians and Surgeons of Canada (RCPSC).
Be within the first two years of their residency program.

Eligible applicants may not hold other ASH awards during the HIP Resident Award term. Applicants in four-year residency programs (Internal Medicine and Pediatrics) are eligible to apply in year one through three of their programs.

Sponsor Details

Sponsor Institute/Organizations: American Society of Hematology

Sponsor Type: Corporate/Non-Profit

Address: 2021 L Street NW, Suite 900, Washington, DC 20036

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity